Precision Dose initiated the recall in response to Amneal’s recall, which included lots repackaged by Precision Dose.
The drugmaker found levels of N-Nitrosodimethylamine in the product higher than the FDA accepts.
Consumers, distributors and retailers with the affected lots should stop use and call Precision dose to obtain a return packet.
Precision Dose has not received any adverse event reports related to the recall.
Read the full news release here.
More articles on pharmacy:
AHA, CVS Health backed secretive anti-pharma group
EpiPen, Humira among drugs Warren wants to regulate
31 drugmakers at high risk for bankruptcy in 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.